Internal: Archive

Power suppliers connect ahead of liberalisation

This content was published on Apr 19, 2001 Under the company name of “Youtility”, the partners want to sell electricity under the brand name “1to1 energy”. The aim of the cooperation is to develop new products and to optimise the quality of service before the official opening of the electricity market. “The aim is to give customers, both small and large, the possibility…

Indian authorities bar CSFB from doing new business

This content was published on Apr 19, 2001 The other nine companies belong to the Nirmal Bang Group and the First Global Finance Group, as well as one sub-broker. SEBI said it took the action because these intermediaries were involved in price manipulation and their actions had harmed investors. The financial market watchdog issued the order after concluding a preliminary investigation into allegations…

Drug firms abandon fight to stop cut-price medicines

This content was published on Apr 19, 2001 The 39 drugs’ firms, which include Switzerland’s Novartis and Roche, decided on Thursday to scrap their challenge to a South African law, which allows the country to import cut-price generic drugs. At the hearing in the high court in Pretoria, they also said they would meet the South African government’s legal costs. The case, brought…

Special audit demanded of SAirGroup

This content was published on Apr 19, 2001 The government and the cantonal authority, which each hold a three per cent stake in the airline group, are both considering taking legal action against the company’s board of directors, all of whom, bar one, announced last month that they would be stepping down. The canton said it would vote to withhold the so-called legal…

Sulzer shareholders vote to spin off Medica

This content was published on Apr 19, 2001 Shares in the group were also suspended at the start of trading on the Swiss bourse while the group’s annual general meeting takes place in Winterthur. Shareholders there are set to decide on the 167-year-old company’s fate, voting to either support current management or cast their lot with Rene Braginsky’s InCentive Capital group, which has…

Sulzer shares suspended while AGM underway

This content was published on Apr 19, 2001 Shareholders are set to decide on the 167-year-old company’s fate, voting to either support current management or cast their lot with Braginsky’s InCentive Capital group, which has mounted the hostile bid worth $1.5 billion ($878 million) for Sulzer’s traditional engineering operations. InCentive wants to replace the present board with its own team of directors, led…

Sika Finance lifts profits

This content was published on Apr 19, 2001 The Swiss-based company, which makes chemicals for the construction industry along with industrial materials for the building sector, said it was raising its dividend to 23 per cent from 21 per cent of its nominal share value. Bearer shares carry a nominal value of SFr60 and registered shares SFr10. “Thanks to our worldwide market presence,…

Credit Suisse buys Spain’s General de Valores

This content was published on Apr 19, 2001 Switzerland’s second largest financial group said the acquisition was still subject to regulatory approval and gave no financial details. General de Valores, based in Barcelona, has 840 million euros (SFr1.3 billion) in assets under management. It has 20,000 clients and a network of 150 financial advisors. The move fits into Credit Suisse’s strategy to serve…

Sales flat at Clariant

This content was published on Apr 19, 2001 The Basel-based group said it expected business to pick-up from around mid-year. “On account of negative currency effects, sales in Swiss francs remained on last year’s level,” it said in a statement. The company said last month that business had had a sluggish start this year because of the difficult situation in the automotive industry,…

Novartis sees pharma sales climb

This content was published on Apr 19, 2001 The Basel-based group said overall sales for the company rose by 11 per cent in local currencies, or by nine per cent in Swiss francs, to SFr7.3 billion in the first quarter. Novartis, which is also Switzerland’s largest company in terms of market capitalisation, expects that its efforts to launch a further five products this…

Internal: Archive

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Internal: Archive

More

Power suppliers connect ahead of liberalisation

More

Indian authorities bar CSFB from doing new business

More

Drug firms abandon fight to stop cut-price medicines

More

Special audit demanded of SAirGroup

More

Sulzer shareholders vote to spin off Medica

More

Sulzer shares suspended while AGM underway

More

Sika Finance lifts profits

More

Credit Suisse buys Spain’s General de Valores

More

Sales flat at Clariant

More

Novartis sees pharma sales climb

Popular Stories

Most Discussed